Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-07-14 4:34 pm Unchanged | 13D | MAGENTA THERAPEUTICS INC MGTA | Atlas Venture Fund X L.P. | 4,117,125 8.7% | 0 (Unchanged) | View |
| 2020-07-07 5:11 pm Sale | 13D | REPLIMUNE GROUP INC REPL | Atlas Venture Fund X L.P. | 2,961,473 7.5% | -436,607 (-12.85%) | View |
| 2020-06-19 5:03 pm Sale | 13D | REPLIMUNE GROUP INC REPL | Atlas Venture Fund X L.P. | 3,398,080 8.6% | -436,507 (-11.38%) | View |
| 2020-02-13 5:00 pm Sale | 13G | MAGENTA THERAPEUTICS INC MGTA | Atlas Venture Fund X L.P. | 4,117,125 10.6% | -726,500 (-15.00%) | View |
| 2019-11-25 5:17 pm Sale | 13D | REPLIMUNE GROUP INC REPL | Atlas Venture Fund X L.P. | 3,834,587 10.8% | -618,799 (-13.90%) | View |
| 2019-07-30 5:25 pm Unchanged | 13D | AVROBIO INC AVRO | Atlas Venture Fund X L.P. | 4,756,478 15.1% | 0 (Unchanged) | View |